The increase in its level can lead to endothelial dysfunction, and subsequently affect the shaping process of placental spiral arteries, resulting in abnormal placental perfusion.18 Both sFlt-1 and PLGF are considered early biomarkers of placental function, and the changes in their concentrations significantly precede the onset of preeclampsia.19 The gene discussed is PGF; the disease is preeclampsia.